Gilead Sciences Depreciation & Amortization 2011-2026 | GILD

Annual Depreciation & Amortization Gilead Sciences

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006
370 M	381 M	354 M	323 M	329 M	288 M	255 M	226 M	233 M	177 M	161 M	125 M	103 M	83 M	72.2 M	67.2 M	64.6 M	51.7 M	36.9 M	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
381 M	36.9 M	195 M

Quarterly Depreciation & Amortization Gilead Sciences

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1	2010-Q3	2010-Q2	2010-Q1	2009-Q3	2009-Q2
93 M	90 M	93 M	97 M	-	94 M	98 M	94 M	-	598 M	598 M	94 M	-	445 M	445 M	80 M	-	239 M	157 M	78 M	-	209 M	136 M	68 M	-	186 M	120 M	60 M	-	169 M	112 M	56 M	-	155 M	103 M	49 M	-	129 M	85 M	42 M	-	116 M	75 M	37 M	-	94 M	53 M	24 M	-	76 M	50.1 M	24 M	-	60.5 M	39.9 M	19.7 M	-	53.2 M	36 M	18.3 M	49.4 M	33.4 M	17.5 M	44.3 M	28.8 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
598 M	17.5 M	118 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Alpine Immune Sciences ALPN	576 K	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Coherus BioSciences CHRS	1.3 M	$ 1.38	-2.82 %	$ 162 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 49.99	-2.89 %	$ 4.5 B	Schweiz
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 29.54	-0.2 %	$ 1.96 B	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Enlivex Therapeutics Ltd. ENLV	332 K	$ 0.7	1.33 %	$ 32 M	Israel
Esperion Therapeutics ESPR	105 K	$ 3.15	0.32 %	$ 655 M	USA
Eton Pharmaceuticals ETON	4.04 M	$ 31.07	1.77 %	$ 836 M	USA
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Exelixis EXEL	29.1 M	$ 53.14	0.27 %	$ 14.4 B	USA
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Forte Biosciences FBRX	64 K	$ 16.84	-0.94 %	$ 218 M	USA
Anika Therapeutics ANIK	5.37 M	$ 14.71	0.96 %	$ 211 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.94	1.03 %	$ 4.84 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA